Stay updated on the most recent developments in Symeres.
We are excited to tell you that this month we celebrated the opening of our first office in the USA at the Cambridge Innovation Center (CIC) at One Broadway, Cambridge, MA. The office will be managed by Dr. Bart DeCorte, Vice President of Business Development for North America.
Bionetix announced they have signed a joint multiyear integrated drug-discovery project, starting from target identification (TI) up to clinical candidate selection on an undisclosed target aimed at acute myeloid leukemia (AML).
It is our great pleasure to announce today that MercachemSyncom has acquired Alcami’s European cGMP CMC drug substance development site, based in Weert, the Netherlands.